Depreciation in USD of Sunshine Biopharma Inc. from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sunshine Biopharma Inc. quarterly/annual Depreciation history and growth rate from 2014 to Q3 2025.
  • Sunshine Biopharma Inc. Depreciation for the quarter ending September 30, 2025 was $95.8K, a 48.3% increase year-over-year.
  • Sunshine Biopharma Inc. Depreciation for the twelve months ending September 30, 2025 was $222K.
  • Sunshine Biopharma Inc. annual Depreciation for 2024 was $147K, a 32.4% increase from 2023.
  • Sunshine Biopharma Inc. annual Depreciation for 2023 was $111K, a 436% increase from 2022.
  • Sunshine Biopharma Inc. annual Depreciation for 2022 was $20.6K, a 62% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Sunshine Biopharma Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $222K $95.8K +$31.2K +48.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $190K $72.5K +$21.7K +42.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $169K $64.8K +$22.2K +52% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $147K -$11.6K Oct 1, 2024 Dec 31, 2024 10-K 2025-04-01
Q3 2024 $64.6K +$27.4K +73.7% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 $50.9K +$16K +45.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $42.6K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q3 2023 $37.2K +$36.4K +4616% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $34.9K +$32.6K +1425% Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-08-20
Q4 2022 $20.6K $14.5K +$11.3K +354% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $9.37K $789 -$2.39K -75.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $11.8K $2.29K -$905 -28.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $12.7K $3.11K -$72 -2.26% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $12.7K $3.18K -$356 -10.1% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-21
Q3 2021 $13.1K $3.18K -$341 -9.68% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $13.4K $3.19K -$299 -8.57% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $13.7K $3.18K -$329 -9.37% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $14.1K $3.54K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 $3.52K +$51.00 +1.47% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $3.49K +$76.00 +2.23% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $3.51K +$97.00 +2.84% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $3.47K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $3.42K Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-31
Q1 2019 $3.41K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18

Sunshine Biopharma Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $147K +$35.8K +32.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-01
2023 $111K +$90.1K +436% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-01
2022 $20.6K +$7.9K +62% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $12.7K -$1.33K -9.42% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-21
2020 $14.1K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2016 $1.81K +$1.33K +278% Jan 1, 2016 Dec 31, 2016 10-K 2017-04-17
2015 $479 +$479 Jan 1, 2015 Dec 31, 2015 10-K 2017-04-17
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.